Development and Optimization of Irinotecan-Loaded PCL Nanoparticles and Their Cytotoxicity against Primary High-Grade Glioma Cells

Background: High-grade gliomas (HGGs) are highly malignant tumors with a poor survival rate. The inability of free drugs to cross the blood–brain barrier and their off-target accumulation result in dose-limiting side effects. This study aimed at enhancing the encapsulation efficiency (EE) of irinote...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoud, Basant Salah, McConville, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068837/
https://www.ncbi.nlm.nih.gov/pubmed/33924355
http://dx.doi.org/10.3390/pharmaceutics13040541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068837/
https://www.ncbi.nlm.nih.gov/pubmed/33924355
http://dx.doi.org/10.3390/pharmaceutics13040541

Ejemplares similares